Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease.

MLA

Donovan, Michael J., et al. “Androgen Receptor Expression Is Associated with Prostate Cancer-Specific Survival in Castrate Patients with Metastatic Disease.” BJU International, vol. 105, no. 4, Feb. 2010, pp. 462–67. EBSCOhost, https://doi.org/10.1111/j.1464-410X.2009.08747.x.

APA

Donovan, M. J., Osman, I., Khan, F. M., Vengrenyuk, Y., Capodieci, P., Koscuiszka, M., Anand, A., Cordon-Cardo, C., Costa, J., & Scher, H. I. (2010). Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease. BJU International, 105(4), 462–467. https://doi.org/10.1111/j.1464-410X.2009.08747.x

Chicago

Donovan, Michael J, Iman Osman, Faisal M Khan, Yevgen Vengrenyuk, Paola Capodieci, Michael Koscuiszka, Aseem Anand, Carlos Cordon-Cardo, Jose Costa, and Howard I Scher. 2010. “Androgen Receptor Expression Is Associated with Prostate Cancer-Specific Survival in Castrate Patients with Metastatic Disease.” BJU International 105 (4): 462–67. doi:10.1111/j.1464-410X.2009.08747.x.